文献速递肝病

毒蕈中毒所致重型肝炎患者的特征及与结局相关的因素

Features of Patients With Severe Hepatitis Due to Mushroom Poisoning and Factors Associated With Outcome.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-02-09

该研究纳入1997年1月至2014年12月在加利福尼亚州旧金山一家三级医疗中心急诊科就诊的27例摄入野生蘑菇后24小时内出现严重肝损伤(转氨酶大于400 IU/L)的患者,分析其人口学、临床表现、实验室指标及治疗,评估蘑菇中毒死亡率并识别与生存和肝移植相关的变量。

要点

  • 24例为毒鹅膏(Amanita phalloides)中毒,3例为Amanita ocreata中毒。
  • 23例未行肝移植存活,4例结局不良(1例肝移植,3例死于肝衰竭)。
  • 天冬氨酸氨基转移酶峰值低于4000 IU/L、国际标准化比值峰值低于2、血清因子V大于30%可识别结局良好患者,阳性预测值均为100%。

核心结论

  • 在27例蘑菇(鹅膏属)中毒所致肝细胞损伤且总胆红素峰值大于2 mg/dL的患者中,肝移植或死亡的概率为17%,符合Hy法则。
  • 天冬氨酸氨基转移酶峰值低于4000 IU/L的患者可在当地医院监测,而峰值更高者应转至肝移植中心。
  • 女性和年龄较大的患者比男性和年轻患者更可能出现不良结局。

研究设计与样本

  • 研究收集了1997年1月至2014年12月在加利福尼亚州旧金山一家三级医疗中心急诊科就诊的27例患者(13例男性;中位年龄47岁)的信息,这些患者在摄入野生蘑菇后24小时内就诊并出现严重肝损伤(血清转氨酶大于400 IU/L),接受了活性炭和N-乙酰半胱氨酸治疗。
  • 所有患者均排除了病毒性肝炎、自身免疫性肝病、对乙酰氨基酚、水杨酸盐中毒和慢性肝病。
  • 分析了患者人口学特征、摄入后时间、就诊症状、实验室值和所接受的治疗;良好结局定义为无需肝移植的生存,不良结局定义为死亡或肝移植。

主要发现

  • 肝损伤归因于摄入毒鹅膏(Amanita phalloides)者24例,归因于Amanita ocreata者3例。
  • 24例随餐摄入蘑菇,3例为致幻目的摄入。
  • 摄入后24-48小时,所有患者血清丙氨酸氨基转移酶范围为554至4546 IU/L(中位2185 IU/L)。
  • 5例发生急性肾损伤。
  • 23例未行肝移植存活,4例结局不良(1例女性在摄入蘑菇后第20天接受肝移植,3例女性死于肝衰竭)。

关键数值与推荐

  • 严重肝损伤定义为血清转氨酶大于400 IU/L。
  • 良好结局定义为无需肝移植的生存;不良结局定义为死亡或肝移植。
  • 天冬氨酸氨基转移酶峰值低于4000 IU/L、国际标准化比值峰值低于2、血清因子V大于30%的阳性预测值均为100%。

临床怎么用

  • 作者认为,天冬氨酸氨基转移酶峰值低于4000 IU/L的患者可在当地医院监测,而峰值更高者应转至肝移植中心。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acute liver failure after ingestion of toxic mushrooms is a significant medical problem. Most exposures to toxic mushrooms produce no symptoms or only mild gastroenteritis, but some lead to severe hepatic necrosis and fulminant hepatic failure requiring liver transplantation. We aimed to assess mortality from mushroom poisoning and identify variables associated with survival and liver transplantation. METHODS: We collected information from 27 patients (13 male; median age, 47 years) admitted to the emergency department within 24 hours of ingesting wild mushrooms. They developed severe liver injury (serum levels of transaminases greater than 400 IU/L) and were treated with activated charcoal and N-acetylcysteine at a tertiary medical center in San Francisco, California from January 1997 through December 2014. Viral hepatitis, autoimmune liver disease, acetaminophen, salicylate toxicity, and chronic liver diseases were ruled out for all patients. We analyzed patient demographics, time since ingestion, presenting symptoms, laboratory values, and therapies administered. A good outcome was defined as survival without need for liver transplant. A poor outcome was defined as death or liver transplant. Positive predictive values were calculated, and the χ2 test was used to analyze dichotomous variables. RESULTS: Liver injury was attributed to ingestion of Amanita phalloides in 24 patients and Amanita ocreata in 3 patients. Twenty-four of the patients ingested mushrooms with meals and 3 patients for hallucinogenic purpose. At 24-48 hours after ingestion, all patients had serum levels of alanine aminotransferase ranging from 554 to 4546 IU/L (median, 2185 IU/L). Acute renal impairment developed in 5 patients. Twenty-three patients survived without liver transplantation, and 4 patients had poor outcomes (1 woman underwent liver transplantation on day 20 after mushroom ingestion, and 3 women died of hepatic failure). Of the 23 patients with peak levels of total bilirubin of 2 mg/dL or more during hospitalization, only 4 had a poor outcome. Peak serum level of aspartate aminotransferase less than 4000 IU/L, peak international normalized ratio less than 2, and a value of serum factor V greater than 30% identified patients with good outcomes with 100% positive predictive value; if these peak values were used as a cutoff, 10 of 27 patients (37%), 7 of 27 patients (26%), and 6 of 12 patients (50%), respectively, could have avoided transfer to a transplant center. CONCLUSIONS: In an analysis of 27 patients with hepatocellular damage due to mushroom (Amanita) poisoning and peak levels of total bilirubin greater than 2 mg/dL, the probability of liver transplantation or death is 17%, fulfilling Hy's law. Patients with peak levels of aspartate aminotransferase less than 4000 IU/L can be monitored in a local hospital, whereas patients with higher levels should be transferred to liver transplant centers. Women and older patients were more likely to have a poor outcome than men and younger patients.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Bonacini M, Shetler K, Yu I, et al. Features of Patients With Severe Hepatitis Due to Mushroom Poisoning and Factors Associated With Outcome. Clin Gastroenterol Hepatol. 2017. PMID: 28189696. doi:10.1016/j.cgh.2016.11.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。